ResearchAI Research

ML Ensembles Detect Cirrhosis in Hepatitis C Patients.

Abrar Alotaibi, Lujain Alnajrani, Nawal Alsheikh, Alhatoon Alanazy, Salam Alshammasi, Meshael Almusairii, Shoog Alrassan, Aisha Alansari· June 26, 2026 View original

Summary

This study investigates the use of explainable ensemble-based machine learning models to detect cirrhosis in Hepatitis C patients, a critical step for early intervention. Using a dataset of Egyptian patients, the Extra Trees model achieved 96.92% accuracy, outperforming other models with fewer features.

Hepatitis C can lead to severe liver damage, including cirrhosis, which often progresses to liver failure. Early detection of cirrhosis is crucial for effective treatment and preventing complications. This research explores the application of machine learning (ML) models to diagnose cirrhosis in Hepatitis C patients, an area previously underexplored by ML. The study utilized a dataset of 2038 Egyptian patients with 28 attributes. Four ensemble-based ML algorithms were trained: Random Forest, Gradient Boosting Machine, Extreme Gradient Boosting, and Extra Trees. The goal was to identify which model could most accurately detect cirrhosis. The Extra Trees model demonstrated superior performance, achieving an accuracy of 96.92%, a recall of 94.00%, and a precision of 99.81%. Notably, it achieved these results using only 16 of the original 28 features, highlighting its efficiency and potential for practical clinical application. This work underscores ML's capability to provide precise diagnostic information for critical medical conditions.

Why it matters

Healthcare professionals can leverage advanced machine learning models for earlier and more accurate detection of diseases like cirrhosis, enabling timely interventions and improving patient outcomes.

How to implement this in your domain

  1. 1Collaborate with data scientists to explore applying ensemble ML models to diagnostic challenges in your medical specialty.
  2. 2Identify relevant patient datasets and ensure data quality and ethical use for model training.
  3. 3Validate ML model performance using independent clinical data to ensure generalizability.
  4. 4Integrate explainable AI techniques to understand model predictions and build clinician trust.
  5. 5Develop a pilot program to test the ML-assisted diagnostic tool in a clinical setting.

Who benefits

HealthcarePharmaceuticalsMedical DevicesHealth Insurance

Key takeaways

  • Machine learning models can accurately detect cirrhosis in Hepatitis C patients.
  • Ensemble methods, particularly Extra Trees, show high diagnostic performance.
  • Early detection of cirrhosis is critical for preventing disease progression.
  • ML can provide precise, data-driven insights for medical diagnosis.

Original post by Abrar Alotaibi, Lujain Alnajrani, Nawal Alsheikh, Alhatoon Alanazy, Salam Alshammasi, Meshael Almusairii, Shoog Alrassan, Aisha Alansari

"arXiv:2606.26561v1 Announce Type: new Abstract: Hepatitis C is a liver infection caused by a virus, which results in mild to severe inflammation of the liver. Over many years, hepatitis C gradually damages the liver, often leading to permanent scarring, known as cirrhosis. Patien…"

View on X

Originally posted by Abrar Alotaibi, Lujain Alnajrani, Nawal Alsheikh, Alhatoon Alanazy, Salam Alshammasi, Meshael Almusairii, Shoog Alrassan, Aisha Alansari on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses